Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing: Invention Described in U.S. Provisional Patent Application - Treatment of Ischemia-Reperfusion Injury With Lipid, Annexin, and Lipid-Annexin Complexes

Federal Register: February 19, 2008 (Volume 73, Number 33)

Notices

Page 9103

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr19fe08-29

Page 9103

DEPARTMENT OF DEFENSE

Department of the Army

Availability for Non-Exclusive, Exclusive, or Partially Exclusive

Licensing of Invention Described in U.S. Provisional Patent Application

Concerning Treatment of Ischemia-Reperfusion Injury with Lipid,

Annexin, and Lipid-Annexin Complexes

AGENCY: Department of the Army, DoD.

ACTION: Notice.

SUMMARY: In accordance with 37 CFR 404.4, 404.6 and 404.7, announcement is made of the availability for licensing of the invention described in

U.S. Provisional Patent Application No. 60/786,527 entitled ``Treatment of Ischemia-Reperfusion Injury with Lipid, Annexin, and Lipid-Annexin

Complexes,'' filed March 27, 2006. Foreign rights are also available

(PCT/US2007/065125). The United States Government, as represented by the Secretary of the Army, has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command,

ATTN: Command Judge Advocate, MCMR-ZA-J, 504 Scott Street, Fort

Detrick, Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth

Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul

Mele, Office of Research & Technology Assessment, (301) 619-6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Disclosed are lipids, annexin, and lipid- annexin complexes for use in the prevention and/or treatment of ischemia-reperfusion injury and reperfusion injury associated with a variety of diseases and conditions. Also disclosed are therapeutic targets and compositions for the prevention and treatment of ischemia- reperfusion injury and diseases and conditions associated with ischemia-reperfusion injury.

Brenda S. Bowen,

Army Federal Register Liaison Officer.

FR Doc. E8-2980 Filed 2-15-08; 8:45 am

BILLING CODE 3710-08-P